Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02686762
Brief Title: Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis (ENCORE-NF)

First Submitted : February 10, 2016
First Submitted that Met QC Criteria : February 16, 2016
First Posted : February 19, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 15, 2019
Last Update Posted : August 19, 2019